Protagenic Therapeutics, Inc. (PTIX:OTC) Annual Reports & Investor Relations Material

Overview

Protagenic Therapeutics, Inc., a New York-based biopharmaceutical company, announced its focus on the discovery and development of therapeutics aimed at treating neuropsychiatric and mood disorders related to stress. With its lead compound, PT00114, the company has produced a synthetic version of teneurin carboxy-terminal associated peptide, a brain signaling peptide that can curb overactive stress responses. Protagenic Therapeutics, Inc. is dedicated to leveraging scientific research to improve the lives of those affected by stress-related disorders.

Annual Reports

Frequently Asked Questions

What is Protagenic Therapeutics, Inc.'s ticker?

Protagenic Therapeutics, Inc.'s ticker is PTIX

What exchange is Protagenic Therapeutics, Inc. traded on?

The company's shares trade on the OTC stock exchange

Where are Protagenic Therapeutics, Inc.'s headquarters?

They are based in New York City, New York

How many employees does Protagenic Therapeutics, Inc. have?

There are 1-10 employees working at Protagenic Therapeutics, Inc.

What is Protagenic Therapeutics, Inc.'s website?

It is http://protagenic.com/

What type of sector is Protagenic Therapeutics, Inc.?

Protagenic Therapeutics, Inc. is in the Technology sector

What type of industry is Protagenic Therapeutics, Inc.?

Protagenic Therapeutics, Inc. is in the Networking & Communication Devices industry

Who are Protagenic Therapeutics, Inc.'s peers and competitors?

The following five companies are Protagenic Therapeutics, Inc.'s industry peers:

- Extreme Networks

- Palo Alto Networks

- Super Micro Computer

- Digi International

- Protagenic Therapeutics, Inc.